B+
Bull case
25%
Probability
Target price
$123.69
Analysis reference price unavailable
Analysis 2026-01-24 · RankAlpha Sentiment AI
AZN
AstraZenecaFNYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Positive late-stage readouts and a favorable FY2025 beat lead to multiple expansion and re-rating toward the upper analyst range within 12 months.
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta 0.0.
What can break
Late-stage clinical trial failure or delay
Momentum
14
Value
64
Sentiment
20
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $97.65 · Bull $123.69 · Bear $79.98Analysis 2026-01-24; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-09 • Model: HYBRID_IC_RP
AI Memo
As of 2026-01-24 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-09-09
Investment thesis
As of 2026-09-09
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-09. Definitions
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $215.39
Why
Momentum14 · Δ7d +3.6
Value64 · Δ7d 0.0
Sentiment20 · Δ7d +4.4
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Confirming evidence
- • Value remains the lead driver in the composite, 7D delta 0.0.
Contradictions & invalidation
- • Late-stage clinical trial failure or delay
- • Macro/currency-driven demand weakness
- • Disappointing guidance, trial setbacks, or regulatory delays compress multiples and push shares toward the lower analyst range.
Catalyst clock
2026-02-10
FY2025 earnings release
Lead driver: Value · See fundamentals
Momentum
14
9% active weight
Current posture
7d trendImproving
Δ7d
+3.6
Δ21d
-0.6
Value
64
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
-0.4
Sentiment
20
62% active weight
Current posture
7d trendImproving
Δ7d
+4.4
Δ21d
+2.3
Why this grade
Composite grade F. Momentum 13.9 / Value 63.9 / Sentiment 20.0
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-01-24. Scenario method
Most likely
B
Base case
60%
Probability
Target price
$97.65
Analysis reference price unavailable
Analysis 2026-01-24 · RankAlpha Sentiment AI
B-
Bear case
15%
Probability
Target price
$79.98
Analysis reference price unavailable
Analysis 2026-01-24 · RankAlpha Sentiment AI
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$242.8B
Beta
0.86
Shares Out
1.55B
P/E (TTM)
29.9
P/S (TTM)
4.81
P/FCF (TTM)
60.77
Rev YoY
+6.4%
EPS YoY
+2.3%
Gross Margin
+73.9%
Op Margin
+22.4%
Net Debt
$23.88B
Current Ratio
0.89
As of 2026-09-09 • Updated nightlySource: Internal modelMethods & Data